ranolazine has been researched along with Nervous System Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diamond, I; Donahue, RR; Garrett, C; Gould, HJ; Paul, D; Taylor, BK | 1 |
| Blankstein, R; Bui, AH; M Blum, R; Southard, RA | 1 |
2 other study(ies) available for ranolazine and Nervous System Disorders
| Article | Year |
|---|---|
Ranolazine attenuates behavioral signs of neuropathic pain.
Topics: Acetanilides; Animals; Ataxia; Behavior, Animal; Cold Temperature; Drug Evaluation, Preclinical; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Nervous System Diseases; Neuralgia; Pain Measurement; Pain Threshold; Physical Stimulation; Piperazines; Random Allocation; Ranolazine; Rats; Rats, Sprague-Dawley; Reaction Time; Sodium Channel Blockers | 2009 |
Neurologic adverse effects of ranolazine in an elderly patient with renal impairment.
Topics: Acetanilides; Aged, 80 and over; Angina Pectoris; Dose-Response Relationship, Drug; Female; Humans; Kidney Diseases; Nervous System Diseases; Piperazines; Ranolazine | 2013 |